Compare ACU & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACU | ACB |
|---|---|---|
| Founded | 1867 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.7M | 232.3M |
| IPO Year | 1994 | 2016 |
| Metric | ACU | ACB |
|---|---|---|
| Price | $61.21 | $3.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $50.00 | N/A |
| AVG Volume (30 Days) | 36.8K | ★ 963.0K |
| Earning Date | 04-23-2026 | 06-17-2026 |
| Dividend Yield | ★ 1.56% | N/A |
| EPS Growth | ★ 1.63 | N/A |
| EPS | ★ 1.46 | N/A |
| Revenue | ★ $196,541,816.00 | N/A |
| Revenue This Year | $5.67 | $6.31 |
| Revenue Next Year | $5.25 | N/A |
| P/E Ratio | $42.42 | ★ N/A |
| Revenue Growth | ★ 1.05 | N/A |
| 52 Week Low | $35.50 | $2.56 |
| 52 Week High | $64.17 | $6.67 |
| Indicator | ACU | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 55.04 | 59.47 |
| Support Level | $39.97 | $3.68 |
| Resistance Level | $63.79 | $3.91 |
| Average True Range (ATR) | 1.97 | 0.13 |
| MACD | -0.45 | -0.04 |
| Stochastic Oscillator | 41.42 | 40.43 |
Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.